Cite
HARVARD Citation
Herrera, S. et al. (2020). Extending cytomegalovirus prophylaxis in high‐risk (D+/R−) lung transplant recipients from 6 to 9 months reduces cytomegalovirus disease: A retrospective study. Transplant infectious disease. 22 (4), p. n/a. [Online].